•
CL
CLNN
Clene Inc. Common Stock
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
61.13M
Volume
131.13K
52W High
$13.50
52W Low
$2.28
Open
$0.00
Prev Close
$4.73
Day Range
0.00 - 0.00
About Clene Inc. Common Stock
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Latest News
Clene to Provide CNM-Au8® ALS Program Update
GlobeNewswire Inc.•Dec 2
Clene Posts 70% Revenue Drop in Q2
The Motley Fool•Aug 14
Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire Inc.•Sep 3
Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire
GlobeNewswire Inc.•Jul 17
Crude Oil Down 1%; Soligenix Shares Surge - Helen Of Troy (NASDAQ:HELE) - Benzinga
Benzinga•Jul 9
Clene to Present at H.C. Wainwright’s 5th Annual Neuro Perspectives Virtual Conference
GlobeNewswire Inc.•Jun 24
Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for Rett Syndrome
GlobeNewswire Inc.•Jun 21
Clene Presents Extended Survival Data Through 3.5 Years and New NfL Responder Results with CNM-Au8® 30 mg Treatment from the HEALEY ALS Platform Trial Open Label Extension at the 2024 ENCALS Meeting
GlobeNewswire Inc.•Jun 18